Latest Financial Updates

Read latest financial news update from our blog

LA Times' Executive Editor Resigns Amid Controversy
LA Times' Executive Editor Resigns Amid Controversy

News Media by Daniel Johnson Resignation Of LA Times’ First Black Executive Editor Sparks...

Admin | Finance | 2 months ago

China holds benchmark lending rates steady
China holds benchmark lending rates steady

China’s benchmark lending rates were kept steady after the central bank held its key polic...

Admin | Finance | 2 months ago

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mercury Systems, and Onsemi and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mercury Systems, and Onsemi and Encourages Investors to Contact the Firm

NEW YORK, Jan. 21, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally reco...

Admin | Finance | 2 months ago

Tesla FSD Beta Version 12 Rolling Out To Customers
Tesla FSD Beta Version 12 Rolling Out To Customers

Tesla FSD Beta Version 12 Rolling Out To Customers In this article: Tesla FSD Beta Versi...

Admin | Finance | 2 months ago

China leaves lending benchmark LPRs unchanged as expected By Reuters
China leaves lending benchmark LPRs unchanged as expected By Reuters

Published Jan 21, 2024 08:22PM ET © Reuters. FILE PHOTO: Paramilitary police officers sta...

Admin | Finance | 2 months ago

Apple Vision Pro Future Uncertain Amid Developer Distaste
Apple Vision Pro Future Uncertain Amid Developer Distaste

Two weeks before its debut, Apple’s Vision Pro is reportedly facing an uncertain future....

Admin | Finance | 2 months ago

UBP Boosts Expectations in Dubai
UBP Boosts Expectations in Dubai

Based on the strong growth in the Middle East, Geneva private bank Union Bancaire Privée i...

Admin | Finance | 2 months ago

Botannix Pharmaceuticals’ resubmission of Sofdra NDA accepted by FDA
Botannix Pharmaceuticals’ resubmission of Sofdra NDA accepted by FDA

Join our daily newsletter At The Bell to receive exclusive market insights Botannix Pharm...

Admin | Finance | 2 months ago

Join Our Newsletter

join our newsletter to receive update from us